Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-13-058594
Filing Date
2013-10-24
Accepted
2013-10-24 15:48:36
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 122039
  Complete submission text file 0000000000-13-058594.txt   169298
Mailing Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017
Business Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017 212-300-2131
Actinium Pharmaceuticals, Inc. (Filed for) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 6770 Blank Checks